<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptor (PPAR)-delta regulates fatty acid oxidation and improves insulin sensitivity </plain></SENT>
<SENT sid="1" pm="."><plain>We screened six single nucleotide polymorphisms (SNPs) of the PPAR-delta gene (PPARD) for an association with the conversion from <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in 769 subjects participating in the STOP-<z:mp ids='MP_0002057'>NIDDM</z:mp> trial </plain></SENT>
<SENT sid="2" pm="."><plain>A 2.7-fold increase in the risk of <z:mp ids='MP_0002055'>diabetes</z:mp> was observed in female carriers of the C allele of rs6902123 (95% CI 1.44-5.30; adjusted P = 0.002) </plain></SENT>
<SENT sid="3" pm="."><plain>In the placebo group, subjects possessing both the 482Ser allele of the PPAR-gamma coactivator-1alpha gene (<z:chebi fb="6" ids="26336">PGC</z:chebi>-1A) and the rare allele of two SNPs of PPARD (rs6902123 and rs3734254) had up to 2.5-fold increased risk for <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, women carrying the C allele of rs6902123 of PPARD and the Pro12Pro genotype of the PPAR-gamma2 gene (PPARG2) had a 3.9-fold (95% CI 1.79-8.63; P = 0.001)-higher risk for <z:mp ids='MP_0002055'>diabetes</z:mp> than women with protective genotypes </plain></SENT>
<SENT sid="5" pm="."><plain>Expression levels of PPAR-delta in subcutaneous adipose tissue of 87 offspring of Finnish patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> did not differ among the genotype groups of SNPs of PPARD </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that SNPs in PPARD modify the conversion from IGT to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, particularly in combination with the SNPs of <z:chebi fb="6" ids="26336">PGC</z:chebi>-1A and PPARG2 </plain></SENT>
</text></document>